GLP-1 drugs like Ozempic have transformed weight loss in the U.S., with nearly 12% of Americans having tried them, according to a new RAND report. Usage is especially high among women aged 50 to 64, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback